Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $170.00
Merck & Co., Inc. (NYSE:MRK – Free Report) had its target price raised by Argus from $145.00 to $170.00 in a research report sent to investors on Tuesday,Benzinga reports. Argus currently has a buy rating on the stock. A number of other equities research analysts have also issued reports on the company. Morgan Stanley raised […]
28 Aug 06:14 · The Markets Daily